Excerpt: The committee has a long bipartisan history of conducting drug safety oversight and is very concerned about these recent developments. We intend to learn more from the FDA, CDC, and others who may provide insight into the details surrounding this outbreak and the prevention of future outbreaks.
To read the letter to FDA, click here.
To read the letter to the CDC, click here.
To read a related press release, click here.